US · Healthcare

Gyre Therapeutics Inc. (GYRE)

Biotechnology

Gyre Therapeutics Inc. (GYRE) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GYRE

P/E ratio

25.00

Gyre Therapeutics Inc. (GYRE) — FAQ

What is GYRE's P/E ratio?

The price-to-earnings (P/E) ratio for Gyre Therapeutics Inc. (GYRE) is 25.00 (data as of 2026-05-23).

Does Gyre Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Gyre Therapeutics Inc. (GYRE). Check the MyAverix Finance app for the latest dividend data.

What sector is Gyre Therapeutics Inc. in?

Gyre Therapeutics Inc. (GYRE) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GYRE listed on?

GYRE is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)